Know Labs (NYSEAMERICAN:KNW) Stock Price Up 3.8% – What’s Next?

Know Labs, Inc. (NYSEAMERICAN:KNW) shares were up 3.8% on Tuesday . The company traded as high as $2.17 and last traded at $2.1390. Approximately 612,050 shares were traded during trading, a decline of 86% from the average session volume of 4,376,964 shares. The stock had previously closed at $2.06.

Know Labs Stock Performance

The stock’s fifty day simple moving average is $2.14 and its 200-day simple moving average is $2.14. The stock has a market cap of $16.04 million, a P/E ratio of -0.33 and a beta of 1.83.

Hedge Funds Weigh In On Know Labs

An institutional investor recently bought a new position in Know Labs stock. Cerity Partners LLC purchased a new position in shares of Know Labs, Inc. (NYSEAMERICAN:KNW) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 80,000 shares of the company’s stock, valued at approximately $158,000. Cerity Partners LLC owned about 1.07% of Know Labs as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 23.96% of the company’s stock.

Know Labs Company Profile

Know Labs, Inc (NYSE American: KNW) is a life sciences company developing non‐invasive sensing solutions based on its proprietary Bio‐RFID platform. The technology employs low‐power radio‐frequency spectroscopy to scan the skin, enabling the detection of biochemical markers such as blood glucose, hydration levels and alcohol concentration without the need for blood draws or fingersticks. By applying sophisticated signal‐processing algorithms to reflected electromagnetic waves, the company aims to deliver real‐time, continuous monitoring devices that could transform standard practices in healthcare and wellness.

The company is focused on advancing its flagship prototype devices through clinical validation studies and regulatory pathways.